Discover
PFE
Pfizer Inc.
26.62
5 x 26.58
1 x 26.59
bid
ask
-
0.43
1.59%
8 @ 04:02 PM
26.59 -0.03 (0.11%)
| Ytd | 6.91% | |
| 1y | 8.30% |
26.47
day range
27.20
23.58
52 week range
28.75
| Open | 26.94 | Prev Close | 27.05 | Low | 26.47 | High | 27.20 | Mkt Cap | 151.72B |
| Vol | 0.00 | Avg Vol | 41.99M | EPS | 3.05 | P/E | 8.73 | Forward P/E | 9.26 |
| Beta | 0.28 | Short Ratio | 3.21 | Inst. Own | 70.28% | Dividend | 1.72 | Div Yield | 6.43 |
| Ex Div Date | 07-24 | Earning | 08-04 | 50-d Avg | 25.09 | 200-d Avg | 25.88 | 1yr Est | 28.64 |
| Income Statement | |||
| Total Revenue | 15.03B | ||
| Revenues (USD) | 15.03B | ||
| Cost of Revenue | 4.09B | ||
| Gross Profit | 10.94B | ||
| Operating Expenses | 11.59B | ||
| Research and Development Expense | 2.81B | ||
| Selling, General and Administrative Expense | 3.41B | ||
| Operating Income | -652.00M | ||
| Income Tax Expense | -407.00M | ||
| Net Income | -247.00M | ||
| Net Income Common Stock | -248.00M | ||
| Net Income Common Stock (USD) | -248.00M | ||
| Consolidated Income | -237.00M | ||
| Net Income from Discontinued Operations | -8.00M | ||
| Net Income to Non-Controlling Interests | 10.00M | ||
| Earnings per Basic Share | -0.04 | ||
| Earnings per Basic Share (USD) | -0.04 | ||
| Earnings per Diluted Share | -0.04 | ||
| Dividends per Basic Common Share | 0.43 | ||
| Earning Before Interest & Taxes (EBIT) | -654.00M | ||
| Earning Before Interest & Taxes (USD) | -654.00M | ||
| Preferred Dividends Income Statement Impact | 1000.00K | ||
| Weighted Average Shares | 5.70B | ||
| Weighted Average Shares Diluted | 5.70B | ||
| Balance Sheet | |||
| Cash and Equivalents | 976.00M | ||
| Cash and Equivalents (USD) | 976.00M | ||
| Investments | 12.28B | ||
| Investments Current | 10.72B | ||
| Investments Non-Current | 1.56B | ||
| Trade and Non-Trade Receivables | 12.49B | ||
| Current Assets | 41.36B | ||
| Property, Plant & Equipment Net | 19.03B | ||
| Total Assets | 201.13B | ||
| Debt Current | 2.70B | ||
| Total Debt | 63.19B | ||
| Current Liabilities | 32.65B | ||
| Debt Non-Current | 60.50B | ||
| Total Liabilities | 115.64B | ||
| Accumulated Retained Earnings (Deficit) | 112.09B | ||
| Accumulated Other Comprehensive Income | -7.22B | ||
| Shareholders Equity | 85.19B | ||
| Shareholders Equity (USD) | 85.19B | ||
| Assets Non-Current | 159.77B | ||
| Total Debt (USD) | 63.19B | ||
| Goodwill and Intangible Assets | 118.47B | ||
| Inventory | 9.95B | ||
| Liabilities Non-Current | 82.99B | ||
| Trade and Non-Trade Payables | 4.58B | ||
| Tax Assets | 14.48B | ||
| Tax Liabilities | 6.43B | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 1.62B | ||
| Net Cash Flow from Financing | -3.66B | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -727.00M | ||
| Capital Expenditure | -533.00M | ||
| Net Cash Flow - Business Acquisitions and Disposals | 1.88B | ||
| Issuance (Repayment) of Debt Securities | -1.19B | ||
| Payment of Dividends & Other Cash Distributions | -2.45B | ||
| Net Cash Flow from Investing | 2.11B | ||
| Net Cash Flow - Investment Acquisitions and Disposals | 765.00M | ||
| Net Cash Flow from Operations | 835.00M | ||
| Effect of Exchange Rate Changes on Cash | -4.00M | ||
| Share Based Compensation | 249.00M | ||